Location: Home
  • search
  • go
  • Relate News
  • 1/8/2020HK Researcher Discovers Anticancer NCE Phorbiplatin
  • 1/7/2020Innovent and Sirnaomics Cooperate to Combine Sintilimab and RNAi in th...
  • 1/7/2020Sorrento, Mabpharm File NDA for Infliximab Biosimilar
  • 1/7/2020NMPA Issues Interim Guidelines for Use of Real-World Data to Support D...
  • 1/6/2020GlycoMimetics and Apollomics Agree to Develop and Commercialize Uprole...
  • 1/6/2020Boehringer Ingelheim's Bet on Chinese CDMO Market Pays Off with Beigen...
  • 1/6/2020Eisai Launches First-in-Class Anti-epileptic Fycompa in China
  • 1/3/2020Recent Executive Moves
  • 1/3/2020CDMO WuXi STA Opens Manufacturing Facility to Produce Oligonucleotides
  • 1/3/2020NHC Issues the Clinical Pathways for Relevant Disease Groups (2019)
  • 1/3/2020Amgen Closes Acquisition of 20.5% Stake in BeiGene for $2.8B
  • 1/2/2020U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must Not Mi...
  • 1/2/2020NHC and SATCM Issues Rules for Internal Price Practices of Medical Ins...
  • 1/2/2020AstraZeneca Granted Chinese Approval for Its Hyperkalaemia Drug ZS-9
  • 12/31/2019Financial-related Company News in Brief
  • 12/31/2019NMPA Announces Initiation of Drug Business Application System
  • 12/30/2019Bankrupt Achaogen Sells China Assets to Xuanzhu for $4.5M
  • 12/30/2019China's 'Seaweed' Alzheimer's Drug Is Now Available to Patients
  • 12/30/2019NMPA Issues the Principles and Procedures for Drug Sampling
  • 12/30/2019Boehringer Ingelheim Approved to Manufacture Tislelizumab in China for...
  • 12/29/2019China Adopts New Law to Promote Basic Medical and Health Care
  • 12/27/2019Recent Executive Moves
  • 12/27/2019China Launches Mental Health Initiative for Students
  • 12/27/2019NMPA Initiates Drug Import & Export Permit Management System
  • 12/27/2019Janssen Secured Chinese Approval of Psoriasis Drug Tremfya (Gussetizum...
  • 12/26/2019Sanofi Files NDA for the World's Atopic Dermatitis Biologic Dupilumab ...
  • 12/26/2019China Lists Lemazolam for Regulation as Class 2 Psychotropic
  • 12/25/2019CDE Solicits Comments on Guidelines for Clinical Protocol of Biosimila...
  • 12/23/2019NMPA Issues the Technical Guidelines for Clinical Comparability Studie...
  • 12/23/2019BeiGene Announces Acceptance of a China sNDA for REVLIMID in Relapsed ...
  • Page:128/360 Total number of articles:10791: [First][<<] [126] [127] [128] [129] [130] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group